Drugs / NM-3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00046696 | May 2001 → Oct 2006 | neoplasm | Genzyme, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NM-3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00046696 ↗ |
| Route | Oral | “Administered Orally” NCT00046696 ↗ |